PDB34 - Assessment of The Economic Value Of Dpp-4 Inhibitor Alogliptin Compared With Sitagliptin, Saxagliptin, And Linagliptin

Autor: Pedrazzoli, M., Pasquini, F., Minda, K.
Zdroj: In Value in Health November 2014 17(7):A337-A337
Databáze: ScienceDirect